Suppr超能文献

[成人慢加急性肝衰竭患者肝移植的现状]

[Current status of liver transplantation for adult patients with acute-on-chronic liver failure].

作者信息

Wu R L, Zhao H C, Geng X P

机构信息

Department of General Surgery,the First Affiliated Hospital of Anhui Medical Univeristy,Hefei 230022,China.

出版信息

Zhonghua Wai Ke Za Zhi. 2022 Feb 1;60(2):181-187. doi: 10.3760/cma.j.cn112139-20210810-00369.

Abstract

Acute-on-chronic liver failure(ACLF) is the most severe form of acute decompensation that develops in patients with chronic liver disease or liver cirrhosis,and is always accompanied by one or more extrahepatic organ failure, and has an extremely poor short-term prognosis. The causes triggering ACLF are complex and diverse,and the clinical stage and the type and the definition of organ failure differ greatly from one another. Therefore, a universally accepted diagnostic criteria for ACLF is not to be defined, and the epidemiological data and patient outcomes on ACLF are not easy to predict and compare among different regions. Accumulating evidence has shown that liver transplantation(LT) plays a significant role in the surgical treatment of patients with ACLF,but its clinical value is still controversial. The specific management and treatment strategy after the admission of patients with ACLF has not yet formed a unified and standardized process or opinions, which includes the monitoring in the ICU,the support and maintenance of organ functions, the selection of the surgical indication and the timing for LT and so on. Moreover, there still exists many controversies concerning, for example, whether patients with ACLF should receive greater priority for organ allocation compared to other potential candidates on the waiting list. Besides, more prospective controlled studies are urgently needed to investigate the role of the artificial liver support system in the bridging therapy to LT. The aim of this article is to review the indication selection of patients with ACLF suitable for LT,the survival outcomes and prognostic factors after LT, the selection of timing, the organ allocation policy and the bridging therapy to LT, which intends to provide new direction for designing the future clinical studies on LT in patients with ACLF.

摘要

慢加急性肝衰竭(ACLF)是慢性肝病或肝硬化患者发生的最严重的急性失代偿形式,常伴有一个或多个肝外器官功能衰竭,短期预后极差。引发ACLF的病因复杂多样,临床分期、器官功能衰竭的类型及定义差异很大。因此,尚未有一个普遍认可的ACLF诊断标准,不同地区关于ACLF的流行病学数据和患者预后也不易预测和比较。越来越多的证据表明,肝移植(LT)在ACLF患者的外科治疗中发挥着重要作用,但其临床价值仍存在争议。ACLF患者入院后的具体管理和治疗策略尚未形成统一、规范的流程或意见,包括在重症监护病房的监测、器官功能的支持和维持、肝移植手术指征的选择及时机等。此外,对于ACLF患者是否应比其他潜在候选者在等待名单上获得更高的器官分配优先级等问题仍存在许多争议。此外,迫切需要更多前瞻性对照研究来探讨人工肝支持系统在肝移植桥接治疗中的作用。本文旨在综述适合肝移植的ACLF患者的适应证选择、肝移植后的生存结局和预后因素、时机选择、器官分配政策以及肝移植桥接治疗,旨在为未来设计ACLF患者肝移植的临床研究提供新方向。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验